AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2021

May 18, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AGIOS PHARMACEUTICALS, INC. (AGIO)
CIK: 0001439222
Period of Report: 2021-05-14

Reporting Person: Miles Darrin (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-14	Common stock	S	3462	$55.41	Disposed	7209	Direct

Footnotes

F1: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $55.40 to $55.47. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.